FARMINGTON, Conn., July 20, 2018 /PRNewswire-PRWeb/ -- Mobile Sense Technologies, Inc. (Mobile Sense), a medical
"I am excited about Mobile Sense's wearable technology for arrythmia detection," said Gray. "The upper arm-based design and the embedded algorithms into smart watches offers a distinct approach to cardiac monitoring. The team has strong partners and a solid technology and I look forward to helping shape their commercialization efforts."
Mobile Sense is building foundational technology enabling off-the-chest wearables for long-term management of cardiac arrhythmias. The traditional cardiac monitoring market relies on seeing a specialist known as an electrophysiologist (EP) to make a diagnosis. Mobile Sense enables users to do a first pass screen of their own cardiac signals using smart watch technology, with the possibility for long-term monitoring on the upper arm as prescribed by a cardiologist. The company recently won the Johnson & Johnson Innovation, JLABS @ NYC Quickfire Challenge and is now a JLABS @ NYC resident company.
"The addition of Steve Gray to our board adds significant insight and knowledge into the cardiac monitoring space and advances our efforts towards commercialization," said Justin Chickles, CEO and co-founder. "We are also thrilled about winning the QuickFire challenge and we are looking forward to the amazing opportunity this represents to connect into the startup community."
Mobile Sense continues to be a part of UConn's Technology Incubation Program facility in Farmington. With investments from Connecticut Innovations and SBIR grants from the National Science Foundation and the National Institute of Health, Mobile Sense aims to expand diagnosis of patients with arrhythmias through long term, non-invasive digital health monitoring.
"Steve brings leadership and deep medical device and diagnostic experience to the Mobile Sense Board of Directors," said Patrick O'Neill, Director of Investments for Connecticut Innovations. "As the company continues to progress forward and engage with investors, Steve's arrival at this time is a welcome addition to the company's already solid foundation."
About Mobile Sense Technologies, Inc. Mobile Sense provides platform technology enabling off-the-chest medical wearables for highly sensitive and specific detection and long-term management of cardiac arrhythmias by peering through the noise to capture clear signals. They are replacing today's invasive and inconvenient cardiac monitoring technology which includes wires and patches, with simple easy to use, wearable devices. Mobile Sense is led by CEO and Co-Founder, Justin Chickles, a serial entrepreneur and startup veteran and former medical device innovator and leader at Johnson & Johnson. Prof. Ki. Chon, Chair of Biomedical Engineering at the University of Connecticut, is the CTO and Co-Founder of Mobile Sense and developed the technology while at the University of Connecticut, Worcester Polytech Institute, and the State University of New York. Mobile Sense investors include Connecticut Innovations and angel investors. Mobile Sense is in process of raising their Series A - http://www.mobilesensetech.com/
Mobile Sense Technologies, Inc. is a resident company of Johnson & Johnson Innovation, JLABS, a premier life science incubator program. JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-enhancing health and wellness solutions to patients around the world. As a leader in innovation, JLABS helps entrepreneurs in pharmaceutical, medical device, consumer, and health tech bring healthcare solutions to patients and consumers.
SOURCE Mobile Sense Technologies
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All